NCT06741137 A Pilot Study of the Effect of the Combination of Inhaled Nitric Oxide and Prone Position Under EIT Monitoring on Efficacy in Patients with ARDS
| NCT ID | NCT06741137 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northern Jiangsu People's Hospital |
| Condition | ARDS |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigating the Impact of Combined Inhaled Nitric Oxide and Prone Positioning on the Efficacy in ARDS Patients
Eligibility Criteria
Inclusion Criteria: 1. Age 18-80 years; 2. Patients with moderate to severe ARDS on mechanical ventilation Exclusion Criteria: 1. Patients with severe asthma or acute exacerbation of chronic obstructive pulmonary disease (COPD), lung tumors, post-lung resection, and post-lung transplantation. 2. Patients with hemodynamic instability requiring vasopressor support: dopamine or dobutamine \>15 µg/kg/min, norepinephrine \>0.3 µg/kg/min. 3. Cardiogenic pulmonary edema. 4. Patients with severe facial deformities, facial trauma, or severe thoracoabdominal trauma that precludes prone positioning ventilation. 5. Mid to late pregnancy. 6. Patients with a history of malignancy or other irreversible diseases/conditions, including those in the terminal stage. 7. Patients expected to be discharged soon or requiring invasive mechanical ventilation for less than 24 hours. 8. Patients currently participating in other studies.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06741137 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying ARDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06741137 currently recruiting?
Yes, NCT06741137 is actively recruiting participants. Contact the research team at 1504572590@qq.com for enrollment information.
Where is the NCT06741137 trial being conducted?
This trial is being conducted at Yangzhou, China.
Who is sponsoring the NCT06741137 clinical trial?
NCT06741137 is sponsored by Northern Jiangsu People's Hospital. The trial plans to enroll 30 participants.